Association of immunoglobulin G N-glycosylation with carotid atherosclerotic plaque phenotypes and actual clinical cardiovascular events: a study protocol for a longitudinal prospective cohort study

Introduction Immune-inflammatory response plays a key role in the pathogenesis of atherosclerosis. IgG N-glycosylation is reported to be associated with the 10-year atherosclerotic cardiovascular disease risk score and subclinical atherosclerosis. However, the relationship of IgG glycosylation with...

Full description

Saved in:
Bibliographic Details
Main Authors: Gehendra Mahara, Hongxia Zhang, Cuihong Tian, Xuerui Tan
Format: Article
Language:English
Published: BMJ Publishing Group 2022-07-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/7/e058922.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832576232747696128
author Gehendra Mahara
Hongxia Zhang
Cuihong Tian
Xuerui Tan
author_facet Gehendra Mahara
Hongxia Zhang
Cuihong Tian
Xuerui Tan
author_sort Gehendra Mahara
collection DOAJ
description Introduction Immune-inflammatory response plays a key role in the pathogenesis of atherosclerosis. IgG N-glycosylation is reported to be associated with the 10-year atherosclerotic cardiovascular disease risk score and subclinical atherosclerosis. However, the relationship of IgG glycosylation with actual clinical cardiovascular disease (CVD) events and plaque phenotypes has rarely been investigated. Therefore, this study aims to understand whether IgG glycosylation traits are correlated with actual clinical CVD events and plaque phenotypes.Methods and analysis Designed to verify the efficacy of IgG glycosylation as a risk for CVD events and screen potential biomarkers of CVD to prevent atherosclerosis occurrence, this longitudinal prospective cohort study will be conducted at the First Affiliated Hospital of Shantou University Medical College, China. In total, 2720 participants routinely examined by carotid ultrasound will be divided into different groups according to plaque phenotype characteristics. Ultra-performance liquid chromatography will be performed to separate and detect IgG N-glycans in serum collected at baseline and at the end of the first, second and third years. The primary outcome is the actual clinical CVD composite events, including non-fatal myocardial infarction, death due to coronary heart disease, and fatal or non-fatal stroke.Ethics and dissemination The Clinical Ethics Committee of the First Affiliated Hospital of Shantou University Medical College approved this study (number: B-2021-127). Findings of this study will be submitted for publication in peer-reviewed journals.Trial registration number ChiCTR2100048740.
format Article
id doaj-art-d46a24d1af7948b4ac0d3070a262b2b7
institution Kabale University
issn 2044-6055
language English
publishDate 2022-07-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-d46a24d1af7948b4ac0d3070a262b2b72025-01-31T09:45:10ZengBMJ Publishing GroupBMJ Open2044-60552022-07-0112710.1136/bmjopen-2021-058922Association of immunoglobulin G N-glycosylation with carotid atherosclerotic plaque phenotypes and actual clinical cardiovascular events: a study protocol for a longitudinal prospective cohort studyGehendra Mahara0Hongxia Zhang1Cuihong Tian2Xuerui Tan3Clinical Research Centre, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, ChinaHealth Care Centre, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, ChinaDepartment of Cardiovascular Medicine, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, ChinaDepartment of Cardiovascular Medicine, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, ChinaIntroduction Immune-inflammatory response plays a key role in the pathogenesis of atherosclerosis. IgG N-glycosylation is reported to be associated with the 10-year atherosclerotic cardiovascular disease risk score and subclinical atherosclerosis. However, the relationship of IgG glycosylation with actual clinical cardiovascular disease (CVD) events and plaque phenotypes has rarely been investigated. Therefore, this study aims to understand whether IgG glycosylation traits are correlated with actual clinical CVD events and plaque phenotypes.Methods and analysis Designed to verify the efficacy of IgG glycosylation as a risk for CVD events and screen potential biomarkers of CVD to prevent atherosclerosis occurrence, this longitudinal prospective cohort study will be conducted at the First Affiliated Hospital of Shantou University Medical College, China. In total, 2720 participants routinely examined by carotid ultrasound will be divided into different groups according to plaque phenotype characteristics. Ultra-performance liquid chromatography will be performed to separate and detect IgG N-glycans in serum collected at baseline and at the end of the first, second and third years. The primary outcome is the actual clinical CVD composite events, including non-fatal myocardial infarction, death due to coronary heart disease, and fatal or non-fatal stroke.Ethics and dissemination The Clinical Ethics Committee of the First Affiliated Hospital of Shantou University Medical College approved this study (number: B-2021-127). Findings of this study will be submitted for publication in peer-reviewed journals.Trial registration number ChiCTR2100048740.https://bmjopen.bmj.com/content/12/7/e058922.full
spellingShingle Gehendra Mahara
Hongxia Zhang
Cuihong Tian
Xuerui Tan
Association of immunoglobulin G N-glycosylation with carotid atherosclerotic plaque phenotypes and actual clinical cardiovascular events: a study protocol for a longitudinal prospective cohort study
BMJ Open
title Association of immunoglobulin G N-glycosylation with carotid atherosclerotic plaque phenotypes and actual clinical cardiovascular events: a study protocol for a longitudinal prospective cohort study
title_full Association of immunoglobulin G N-glycosylation with carotid atherosclerotic plaque phenotypes and actual clinical cardiovascular events: a study protocol for a longitudinal prospective cohort study
title_fullStr Association of immunoglobulin G N-glycosylation with carotid atherosclerotic plaque phenotypes and actual clinical cardiovascular events: a study protocol for a longitudinal prospective cohort study
title_full_unstemmed Association of immunoglobulin G N-glycosylation with carotid atherosclerotic plaque phenotypes and actual clinical cardiovascular events: a study protocol for a longitudinal prospective cohort study
title_short Association of immunoglobulin G N-glycosylation with carotid atherosclerotic plaque phenotypes and actual clinical cardiovascular events: a study protocol for a longitudinal prospective cohort study
title_sort association of immunoglobulin g n glycosylation with carotid atherosclerotic plaque phenotypes and actual clinical cardiovascular events a study protocol for a longitudinal prospective cohort study
url https://bmjopen.bmj.com/content/12/7/e058922.full
work_keys_str_mv AT gehendramahara associationofimmunoglobulingnglycosylationwithcarotidatheroscleroticplaquephenotypesandactualclinicalcardiovasculareventsastudyprotocolforalongitudinalprospectivecohortstudy
AT hongxiazhang associationofimmunoglobulingnglycosylationwithcarotidatheroscleroticplaquephenotypesandactualclinicalcardiovasculareventsastudyprotocolforalongitudinalprospectivecohortstudy
AT cuihongtian associationofimmunoglobulingnglycosylationwithcarotidatheroscleroticplaquephenotypesandactualclinicalcardiovasculareventsastudyprotocolforalongitudinalprospectivecohortstudy
AT xueruitan associationofimmunoglobulingnglycosylationwithcarotidatheroscleroticplaquephenotypesandactualclinicalcardiovasculareventsastudyprotocolforalongitudinalprospectivecohortstudy